{"entity":{"type":"insider","cik":"0001994972","url":"/insider/0001994972","json_url":"/insider/0001994972.json","name":"Adler Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2025-02-21","last":"2025-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Adler Eric","source":"filing","n_filings":5,"first_seen":"2025-02-21","last_seen":"2025-11-20"}],"transactions":[{"id":5101709,"accession":"0001994972-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001994972-25-000005","line_url":"/filing/0001994972-25-000005#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0001994972","owner_name":"Adler Eric","owner_url":"/insider/0001994972","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":615.0,"shares_display":"615","price_per_share":9.27,"price_display":"9.27","price_state":"stated","total_value":5701.05,"total_display":"5,701.05","shares_owned_after":72646.0,"shares_owned_after_display":"72,646","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":5136070,"accession":"0001994972-25-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001994972-25-000003","line_url":"/filing/0001994972-25-000003#line-3","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0001994972","owner_name":"Adler Eric","owner_url":"/insider/0001994972","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3344.0,"shares_display":"3,344","price_per_share":8.935,"price_display":"8.94","price_state":"stated","total_value":29878.64,"total_display":"29,878.64","shares_owned_after":73299.0,"shares_owned_after_display":"73,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-17","scope":"insider"},{"id":5136065,"accession":"0001994972-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001994972-25-000003","line_url":"/filing/0001994972-25-000003#line-2","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0001994972","owner_name":"Adler Eric","owner_url":"/insider/0001994972","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38.0,"shares_display":"38","price_per_share":9.561,"price_display":"9.56","price_state":"stated","total_value":363.318,"total_display":"363.32","shares_owned_after":73261.0,"shares_owned_after_display":"73,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-17","scope":"insider"},{"id":5125643,"accession":"0001415889-25-022475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022475","line_url":"/filing/0001415889-25-022475#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0001994972","owner_name":"Adler Eric","owner_url":"/insider/0001994972","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":608.0,"shares_display":"608","price_per_share":4.668,"price_display":"4.67","price_state":"stated","total_value":2838.144,"total_display":"2,838.14","shares_owned_after":67073.0,"shares_owned_after_display":"67,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4382613,"accession":"0001415889-25-013818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-013818","line_url":"/filing/0001415889-25-013818#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0001994972","owner_name":"Adler Eric","owner_url":"/insider/0001994972","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":585.0,"shares_display":"585","price_per_share":2.774,"price_display":"2.77","price_state":"stated","total_value":1622.79,"total_display":"1,622.79","shares_owned_after":67681.0,"shares_owned_after_display":"67,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":4432921,"accession":"0001415889-25-005109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-005109","line_url":"/filing/0001415889-25-005109#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0001994972","owner_name":"Adler Eric","owner_url":"/insider/0001994972","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2359.0,"shares_display":"2,359","price_per_share":4.413,"price_display":"4.41","price_state":"stated","total_value":10410.267,"total_display":"10,410.27","shares_owned_after":68266.0,"shares_owned_after_display":"68,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001907108","name":"Lexeo Therapeutics, Inc.","url":"/issuer/0001907108","role":"Officer (Chief Medical Officer)","n_filings":5,"first_seen":"2025-02-21","last_seen":"2025-11-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001994972","retrieved_at":"2026-08-22T01:29:59+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}